EODData

FRA, EP3: OraSure Technologies Inc

16 Jan 2026
LAST:

2.300

CHANGE:
 0.06
OPEN:
2.360
HIGH:
2.360
ASK:
0.000
VOLUME:
10.7K
CHG(%):
2.54
PREV:
2.360
LOW:
2.300
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jan 262.3602.3602.3002.30010.7K
15 Jan 262.3002.3802.3002.36010.7K
14 Jan 262.2202.2802.2002.28010.7K
13 Jan 262.3002.3002.1802.22010.7K
12 Jan 262.2402.2802.2002.28010.7K
09 Jan 262.2802.3002.2402.24010.7K
08 Jan 262.1402.2602.1402.26010.7K
07 Jan 262.1202.1202.0602.12010.7K
06 Jan 262.1002.1202.0802.12010.7K
05 Jan 262.0202.1002.0202.10010.7K

PROFILE

Name:OraSure Technologies Inc
About:OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company's products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, the company develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is h
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:220 East First Street, Bethlehem, PA, United States, 18015
Website:https://www.orasure.com
ISIN:US68554V1089
LEI:529900GNNJPNM4XHXQ77

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:25.43 
Forward P/E:9.48 
PEG Ratio:9.48 
Price to Sales:1.16 
Price to Book:0.47 
Profit Margin:-0.48 
Operating Margin:-0.58 
Return on Assets:-0.09 
Return on Equity:-0.15 
Revenue:106.78M 
Shares:73.14M 
Market Cap:168.22M 

TECHNICAL INDICATORS

MA5:2.290.5%
MA10:2.233.2%
MA20:2.147.5%
MA50:2.109.4%
MA100:2.393.8%
MA200:2.477.6%
STO9:69.23
STO14:79.49
RSI14:68.06 
WPR14:-16.22 
MTM14:0.31
ROC14:0.16 
ATR:0.07 
Week High:2.383.5%
Week Low:2.185.5%
Month High:2.383.5%
Month Low:1.997.6%
Year High:3.8768.4%
Year Low:1.8027.8%
Volatility:7.79